FDA Signals Flexibility In Pitch To Reduce Animal Testing
New guidance proposed by the U.S. Food and Drug Administration suggests federal regulators are willing to be flexible as they encourage drug developers to reduce animal testing and shift instead to...To view the full article, register now.
Already a subscriber? Click here to view full article